James Conti

Papers

1

Total Citations

2

H-Index

1

About

Dr. James Conti is a colorectal surgeon and clinical researcher whose work focuses on improving oncologic outcomes in rectal cancer surgery, particularly through the refinement of robotic-assisted techniques. His major contributions center on identifying predictors of positive circumferential resection margins (CRM) after robot-assisted total mesorectal excision (TME)—a critical factor in preventing local recurrence and improving survival. In his most cited work, a 2025 retrospective cohort study, Dr. Conti developed a novel risk model that pinpoints key preoperative and intraoperative variables associated with positive CRM, offering surgeons a practical tool to stratify patients and tailor surgical approaches. This research has already garnered 2 citations in its first year, signaling its immediate relevance to the field. Beyond this study, Dr. Conti’s broader portfolio advances the evidence base for robotic TME, addressing longstanding challenges in achieving clear margins while minimizing morbidity. His work bridges the gap between technical innovation and patient-centered outcomes, making him a rising voice in the push for precision in colorectal oncology. For students and researchers, Dr. Conti exemplifies how rigorous retrospective analysis can directly inform clinical decision-making and surgical quality improvement.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Predictors and risk model for positive circumferential resection margin after robot-assisted total mesorectal excision: retrospective cohort study
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 62

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago